Global Pregabalin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pregabalin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Pregabalin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pregabalin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pregabalin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals
Segment by Type
Tablet
Capsule
Oral Solution
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pregabalin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pregabalin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pregabalin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pregabalin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pregabalin introduction, etc. Pregabalin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pregabalin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pregabalin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pregabalin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pregabalin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals
Segment by Type
Tablet
Capsule
Oral Solution
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pregabalin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pregabalin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pregabalin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pregabalin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pregabalin introduction, etc. Pregabalin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pregabalin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
